Exploring Opportunities to Improve the Quality of Life for Those with Amyotrophic Lateral Sclerosis (ALS) – Findings from the Market Insights Program

Webinar Recorded on April 27, 2023.

Supported through funding by Amylyx.

Download Presentation

This webinar featured a discussion with panelists from AMCP’s Market Insights Roundtable on Exploring Opportunities to Improve the Quality of Life for Those with Amyotrophic Lateral Sclerosis (ALS). Speakers provided an overview of the current and evolving treatment landscape for ALS. 

Amyotrophic lateral sclerosis (ALS) is a rare, rapidly progressive, and fatal neurodegenerative disease characterized by loss of motor neurons in the brain and spinal cord. Current treatments for ALS are largely focused on supportive care. Typically, treatment includes a combination of therapies along with durable medical equipment (DME) to help preserve quality of life as long as possible.

Speakers:

• Ryan Haumschild
  Director of Pharmacy
  Emory Healthcare and Winship Cancer Institute
• Ryan Bitton
  Senior Director, Pharmacy Services 
  Health Plan of Nevada, a UnitedHealthcare company